Publications

State transitions across the Strep A disease spectrum: scoping review and evidence gaps.

Parajulee, P; Lee, J-S; ABBAS, K; Cannon, J; Excler, JL; Kim, JH; Mogasale, V;

2024

BMC Infectious Diseases, (2024).24 1 10.1186/s12879-023-08888-4.

Chikungunya seroprevalence, force of infection, and prevalence of chronic disability after infection in endemic and epidemic settings: a systematic review, meta-analysis, and modelling study.

KANG, H; AUZENBERGS, M; Clapham, H; Maure, C; Kim, J-H; Salje, H; Taylor, CG; LIM, A; CLARK, A; EDMUNDS, WJ; Sahastrabuddhe, S; BRADY, OJ; ABBAS, K;

2024

The Lancet Infectious Diseases, (2024).24 5 10.1016/S1473-3099(23)00810-1.

Systematic review of social determinants of childhood immunisation in low- and middle-income countries and equity impact analysis of childhood vaccination coverage in Nigeria.

Williams, SV; Akande, T; ABBAS, K;

2024

PLoS One, (2024).19 3 10.1371/journal.pone.0297326.

Equity impact of HPV vaccination on lifetime projections of cervical cancer burden among cohorts in 84 countries by global, regional, and income levels, 2010-22: a modelling study.

ABBAS, K; Yoo, KJ; PREM, K; JIT, M;

2024

eClinicalMedicine, (2024).70, 10.1016/j.eclinm.2024.102524.

Safe in pregnancy: A global living systematic review and meta-analysis of COVID-19 vaccines in pregnancy.

Buekens, P; Berrueta, M; Ciapponi, A; Bardach, A; Mazzoni, A; Rodriguez-Cairoli, F; Gottlieb, SL; KAMPMANN, B; PARKER, EP K; Xiong, X; Zaraa, S; Stergachis, A;

2024

Vaccine, (2024).42 7 10.1016/j.vaccine.2024.02.012.

Estimating the health effects of COVID-19-related immunisation disruptions in 112 countries during 2020-30: a modelling study.

Hartner, A-M; Li, X; Echeverria-Londono, S; Roth, J; ABBAS, K; AUZENBERGS, M; De Villiers, MJ; Ferrari, MJ; Fraser, K; FU, H; Hallett, T; Hinsley, W; JIT, M; Karachaliou, A; Moore, SM; Nayagam, S; Papadopoulos, T; Perkins, TA; Portnoy, A; Minh, QT; VYNNYCKY, E; Winter, AK; Burrows, H; CHEN, C; Clapham, HE; ... Gaythorpe, KA M.

2024

The Lancet Global health, (2024).12 4 10.1016/S2214-109X(23)00603-4.

Programmatic considerations and evidence gaps for chikungunya vaccine introduction in countries at risk of chikungunya outbreaks: Stakeholder analysis.

AUZENBERGS, M; Maure, C; KANG, H; CLARK, A; BRADY, O; Sahastrabuddhe, S; ABBAS, K;

2024

PLoS neglected tropical diseases, (2024).18 4 10.1371/journal.pntd.0012075.

Comparative safety and effectiveness of Pfizer BA.4-5 versus Sanofi during the spring 2023 COVID-19 booster vaccination programme in England: a matched cohort study in OpenSAFELY-TPP.

Andrews, CD; PRESTIGE, E; PARKER, EP K; Walker, V; Palmer, T; Schaffer, AL; Green, AC A; Curtis, HJ; Walker, A; Smith, RM; Wood, C; Bates, C; Mehrkar, A; MacKenna, B; Bacon, SC J; GOLDACRE, B; Hernán, MA; Sterne, JA C; Hulme, WJ;

2024

Cold Spring Harbor Laboratory (2024). 10.1101/2024.03.15.24304277.

Research priorities to support typhoid conjugate vaccine decision-making in India: evidence assessment and stakeholder survey.

MOGASALE, VV; Sinha, A; John, J; Hasan Farooqui, H; Ray, A; Chantler, T; Mogasale, V; Dhoubhadel, BG; EDMUNDS, WJ; Clark, A; ABBAS, K;

2024

BMJ public health, (2024).2 2 10.1136/bmjph-2024-001089.

Typhoid conjugate vaccine implementation in India: A review of supportive evidence.

Mogasale, VV; Sinha, A; John, J; Hasan Farooqui, H; Ray, A; CHANTLER, T; Mogasale, V; Gopal Dhoubhadel, B; John Edmunds, W; CLARK, A; ABBAS, K;

2024

Vaccine: X, (2024).21, 10.1016/j.jvacx.2024.100568.